108 related articles for article (PubMed ID: 6809234)
1. [Prevention and therapy of L1210 leukemia in mice, using inactivated and grafted tumor cells, in association with the immunomodulator P40, and Antineoplastic Agents (author's transl)].
Relyveld EH; Bizzini B; Ben-Efraim S
C R Seances Acad Sci III; 1982 Mar; 294(12):571-6. PubMed ID: 6809234
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of L1210 mouse leukemia by immunization with xenogenized tumor cells combined with immunostimulation by the P40 fraction of C. granulosum and chemotherapy.
Relyveld EH; Bizzini B; Ben-Efraim S
Int J Immunopharmacol; 1984; 6(5):445-50. PubMed ID: 6500782
[TBL] [Abstract][Full Text] [Related]
3. Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia.
Relyveld EH; Bizzini B; Ophir R; Ben-Efraim S
Cancer Treat Rep; 1987 Mar; 71(3):241-6. PubMed ID: 3102055
[TBL] [Abstract][Full Text] [Related]
4. [Protective effect of P40 fraction of C. granulosum against leukemia L1210 in mice].
Relyveld EH; Bizzini B; Ben-Efraim S
C R Seances Acad Sci III; 1981 Jul; 293(1):39-42. PubMed ID: 6796201
[TBL] [Abstract][Full Text] [Related]
5. Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
Mathé G; Pouillart P; Lapeyraque F
Br J Cancer; 1969 Dec; 23(4):814-24. PubMed ID: 4312660
[No Abstract] [Full Text] [Related]
6. Active immunotherapy.
Mathé G
Adv Cancer Res; 1971; 14():1-36. PubMed ID: 4330473
[No Abstract] [Full Text] [Related]
7. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
Ohno R; Kodera Y; Ogura M; Yamada H
Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor effect of two adjuvants of CpG ODN on leukemic tumor in mouse models].
He AL; Chen H; Zhang WG; Cao XM; Zhao WH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1042-5. PubMed ID: 17956687
[TBL] [Abstract][Full Text] [Related]
9. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.
Kawalec M; Skórski T; Kawiak J
Invest New Drugs; 1988 Sep; 6(3):169-72. PubMed ID: 3192382
[TBL] [Abstract][Full Text] [Related]
10. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
Mathé G; Kamel M; Dezfulian M; Halle-Pannenko O; Bourut C
Cancer Res; 1973 Sep; 33(9):1987-97. PubMed ID: 4146853
[No Abstract] [Full Text] [Related]
11. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
[No Abstract] [Full Text] [Related]
12. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.
Watanabe T; Itoh S
Cancer Immunol Immunother; 1997 Jun; 44(4):216-20. PubMed ID: 9222280
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity against L1210 mouse leukemia of immunotoxins containing a monoclonal antibody to the glycolipid globotriaosylceramide.
Junqua S; Wiels J; Tursz T; Le Pecq JB
Immunol Lett; 1987 Jan; 14(2):167-72. PubMed ID: 3495489
[TBL] [Abstract][Full Text] [Related]
14. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
[TBL] [Abstract][Full Text] [Related]
15. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
Mathé G
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470
[No Abstract] [Full Text] [Related]
16. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
Nicolin A; Canti G; Marelli O; Veronese F; Goldin A
Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535
[TBL] [Abstract][Full Text] [Related]
17. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
18. Potentiating the effectiveness of influenza vaccination by a combined immunostimulation with P40 immunomodulator: an experimental study in mice.
Fattal-German M; German A; Bizzini B
Biomed Pharmacother; 1988; 42(1):73-8. PubMed ID: 3408809
[TBL] [Abstract][Full Text] [Related]
19. Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.
Verloes R; Atassi G; Dumont P; Kanarek L
Br J Cancer; 1981 Feb; 43(2):201-9. PubMed ID: 7470382
[TBL] [Abstract][Full Text] [Related]
20. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
Okura A; Arakawa H; Yoshinari T; Naito K; Ishizuka M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
